IBD

Advancing Collaborative Approaches in IBD Treatment Decision-Making

March 14, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Advancing Collaborative Approaches in IBD Treatment Decision-Making

March 12, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Jan. 18, 2018

Expand your knowledge, network with IBD leaders, spark innovative research and get inspired to improve patient care.

Putting Patients First: Digital Health Tools to Empower IBD Patients

Jan. 18, 2018

Discover how advances in digital health can help you monitor and support IBD patients remotely and dynamically, improve face-to-face care, and drive clinical decisions through shared decision-making.

Advancing Collaborative Approaches in IBD Treatment Decision-Making

Jan. 9, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

2018 Research Grants Open for Applications

Dec. 11, 2017

Don't lose sight of award deadlines during the busy holiday season. Read on to discover open grants from the AGA Research Foundation and when applications are due.

Crohn's & Colitis Congress Dec. 8 Registration Deadline

Dec. 7, 2017

Last chance to save up to $175 on registration.
Advertisement

Get Your Questions Answered on Biosimilar Therapies

Dec. 7, 2017

Join inflammatory bowel disease (IBD) experts on Dec. 11, 2017, 8-8:45 p.m. ET, for a free webinar on biosimilar therapies.

Lack of Screening a Barrier to HCV Elimination

Nov. 30, 2017

More people need to be diagnosed and treated worldwide to reach WHO targets.

Neurologic Manifestations Rare in IBD, but Potentially Serious

Nov. 30, 2017

Caregivers must be prepared to recognize IBD neurologic complications and be prepared to take quick action.

AGA and Step Therapy Coalition Advocate for Patient Protections

Nov. 30, 2017

Ask your legislator to protect IBD treatment options for your patients.

5 Reasons to Pursue a Career in IBD Research or Patient Care

Nov. 28, 2017

GIs say that inflammatory bowel disease (IBD) is one of the most challenging & rewarding subspecialities.

IBD Drug Monitoring: Where Do You Stand?

Nov. 27, 2017

When it comes to being proactive or reactive, which method makes the most sense?

Help! My IBD Patient Is Failing Conventional Therapy

Nov. 15, 2017

The answer to this common challenge involves a better understanding of the currently available treatments.

Meta-Analysis Findings May Incentivize Mothers with IBD to Breastfeed Longer

Nov. 9, 2017

Reduced risk of IBD, especially with breastfeeding exposure of at least 12 months.

Preparation Crucial for Adolescents Transferring to Adult IBD Care

Nov. 9, 2017

Psychological readiness, logistical barriers and appropriate selection of adult care providers are key.

Grant Spotlight: AGA Pilot Awards

Nov. 8, 2017

Take your new research project idea and make it a reality with an AGA research award. Eight grants are open with a Jan. 12, 2018, deadline.

The Lowdown on the Low-FODMAP Diet

Nov. 1, 2017

As the low-FODMAP diet grows in popularity, know the facts to help answer patient questions and provide guidance.

For IBD Patients, Transitions Are a Challenge

Nov. 1, 2017

IBD experts provide tips to help your patients as they transition from pediatric to adult care, or to a new physician when going off to college.

Concurrent IBD Present in Most Primary Sclerosing Cholangitis

Oct. 26, 2017

Unique phenotype for differentiating primary from IgG4 sclerosing cholangitis, but underlying joint mechanisms unclear.

How to Select the Best FMT Donor

Oct. 25, 2017

Dr. Gail Hecht debunks the myth that a patient’s family or friend is the best donor for a fecal microbiota transplantation.

Can You Explain Biosimilars to Patients?

Oct. 25, 2017

AGA is taking the lead in educating health care professionals and their patients about biosimilars and how they can play a role in IBD patient care.

Agreement Between Home-Based Measurement of Stool Calprotectin and ELISA Results for Monitoring Inflammatory Bowel Disease Activity

Oct. 22, 2017

For patients with concentrations of fecal calprotectin above this level, findings from IBDoc should be confirmed by another method.

Association Between Low Trough Levels of Vedolizumab During Induction Therapy for Inflammatory Bowel Diseases and Need for Additional Doses Within 6 Months

Oct. 22, 2017

We investigated whether serum trough levels of vedolizumab, during the induction phase can determine whether patients need additional doses within 6 months.